MY ACCOUNT | NEWSLETTER |

Response to immunosuppressive therapy in dogs with suspected non-regenerative immune-mediated anemia


This study aimed to determine the response time to immunosuppressive therapy and time required to achieve a 5% increase in hematocrit among dogs with non-regenerative immune-mediated anemia.

Researchers enrolled client-owned dogs diagnosed with non-regenerative immune-mediated anemia between December 2012 and May 2018 in the study. The first treatment regimen included prednisolone (2 mg/kg/day) and ciclosporin (up to 10 mg/kg/day) for eight weeks. 

Dogs that did not respond to the first regimen proceeded to the second regimen comprising prednisolone and mycophenolate mofetil (15 mg/kg, twice a day). Clinicians monitored reticulocyte count and hematocrit every one to two weeks. Treatment response was defined as an absolute reticulocyte count more than 60×103 /μL or increasing hematocrit.

During the study period, 23 dogs fulfilled the inclusion criteria for non-regenerative immune-mediated anemia. Twelve dogs were excluded from this study for assorted reasons and response to therapy was evaluated in the remaining 11 dogs. 

Treatment responses were observed in eight of 11 dogs, and the median time to response was 39.5 days (range 8 to 92 days). 

Two responders were unable to continue the first treatment regimen and were switched to the second regimen owing to anorexia and nausea, possibly induced by ciclosporin; withdrawal of ciclosporin improved their symptoms. The time required to achieve a 5% increase in hematocrit was assessed in the other six dogs, with a median of 55.5 days (range 8 to 135 days).

In conclusion, this study reports the response to a standardized treatment protocol in dogs with non-regenerative immune-mediated anemia. Knowledge of potential side effects and expected therapeutic outcomes may be of use for veterinary practitioners treating this condition.

K Morishita et al. “Evaluation of responses to immunosuppressive therapy in dogs with suspected non-regenerative immune-mediated anaemia: 11 cases (2012-2018).” J Small Anim Pract. 2023 Apr 7. doi: 10.1111/jsap.13614.

Like0
Dislike0
  • Please enter a comment


Name *
Email address *
Comment *


* Required fields

Information on the processing of your personal data
We inform you that, in compliance with the provisions of current national and European regulations for the Protection of Personal Data and Services of the Information Society and Electronic Commerce, by sending us this form you are expressly giving your consent to Grupo Asís Biomedia , SL, (hereinafter, "ASIS GROUP") so that, as the person in charge, it may process your personal data in order to respond to your request for contact and information by electronic means.

Likewise, when you expressly consent, we will process your personal data to send you specialized information, newsletters, offers and exclusive promotions from GRUPO ASIS and related companies.

For the aforementioned purpose, GRUPO ASIS may transfer your data to other companies linked to GRUPO ASIS or to third party service providers for the management of electronic communications and other security services, even in cases where they are outside of the European Union, provided that they legally guarantee the adequate level of protection required by European regulations.

At any time you can withdraw the consent given and exercise the rights of access, rectification, deletion, portability of your data and limitation or opposition to its treatment by contacting GRUPO ASIS by sending an email to protecciondatos @ grupoasis.com, or by written communication to address at Centro Empresarial El Trovador, 8th floor, office I, Plaza Antonio Beltrán Martínez 1, 50002, Zaragoza (Spain), indicating in either case the Ref. Personal data and the right you exercise, as well as attaching a copy of your ID or replacement identification document.


I have read and accept the treatment of my data according to the informed purpose and according Legal notes and the Privacy Policy
I wish to receive commercial information from GRUPO ASIS and related companies



More news

Trends in fluoroquinolone resistance of bacteria isolated from canine urinary tracts

Like0
Dislike0

Teaching Transrectal Palpation of the Internal Genital Organs in Cattle

Like0
Dislike0

Male embryos grow faster: Breakthrough study reveals genetic reasons why

Like0
Dislike0

CityVet Recognized Among Fortune’s 2025 Best Workplaces in Health Care™ and Earns Great Place To Work® Certification for the Third Year in a Row

Like0
Dislike0

Innovations in veterinary markets: opinion leaders' social capital

Like0
Dislike0

Newsletter

 
 

News of interest

EVENTS

Copyright © 2025 - All Rights Reserved
ISSN 2768-198X

Top